coronavirus vaccine they developed and began testing in April 2020. The research was funded by a £20 million ($24 millio

[answerhappygod]

Coronavirus Vaccine They Developed And Began Testing In April 2020 The Research Was Funded By A 20 Million 24 Millio 1 (65.74 KiB) Viewed 196 times

Coronavirus Vaccine They Developed And Began Testing In April 2020 The Research Was Funded By A 20 Million 24 Millio 2 (42.54 KiB) Viewed 196 times

coronavirus vaccine they developed and began testing in April 2020. The research was funded by a £20 million ($24 million) grant from the UK's National Health Service. The vaccine was made from a weakened version of a common cold virus that causes infections in chimpanzees. It was modified to make it impossible to grow in humans. Proteins from the Covid-19 virus's outer coat were then added. "We hoped the body would recognize and develop an immune response to the COVID-19 protein that will help stop the SARS-CoV-2 virus from entering human cells and therefore prevent infection," the University said. In the trial 1,068 volunteers were recruited. They were assigned by a flip of a coin to either be injected with the coronavirus vaccine or to receive a control - a widely available meningitis vaccine. Volunteers, who lived in a variety of locations around the U.K., were then followed for 6 months. The researchers performed laboratory tests each week to determine if the volunteers had contracted COVID-19 (the disease caused by the coronavirus). The following are the results of the study: Number of people Number of cases Number of of COVID-19 COVID-19 deaths 527 53 (10.0%) 15 (2.8%) People who received the coronavirus vaccine People who received the meningitis vaccine 541 97 (17.9%) 31 (5.7%) *Mortality rate is based on the number of people in the study group. Mortality rate can be calculated based on population total or number of cases. Question: Which would be the best controlled variable to add to this experiment to improve the study

peop of COVID-19 COVID-19 deaths 527 53 (10.0%) 15 (2.8%) People who received the coronavirus vaccine People who received the meningitis vaccine 541 97 (17.9%) 31 (5.7%) "Mortality rate is based on the number of people in the study group. Mortality rate can be calculated based on population total or number of cases. Question: Which would be the best controlled variable to add to this experiment to improve the study? Control the temperature inside the participants houses. Control the nutrition level or diet of participants. Control selection of participants based on pre-existing conditions. Control how much sun exposure the participants get. Control how much sleep the participants get.